Skip to main content

Market Overview

Benzinga's Top Pre-Market Losers

Share:

Nektar Therapeutics (NASDAQ: NKTR) dipped 24.19% to $10.50 in the pre-market session after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint.

Zoltek Companies (NASDAQ: ZOLT) shares dropped 10.05% to $16.65 in pre-market trading after Toray Industries agreed to buy Zoltek Companies for $16.75 per share.

J. C. Penney Company (NYSE: JCP) shares fell 8.54% to $9.53 in the pre-market trading after the company priced its underwritten public offering of 84.0 million shares of its common stock at $9.65 per share.

Accenture (NYSE: ACN) dipped 4.18% to $72.70 in the pre-market session after the company reported a rise in its fiscal fourth-quarter net income. For the current fiscal year, the company projected net income of $4.42 to $4.54 per share, versus analysts' expectations of $4.50 per share.

 

Related Articles (NKTR + JCP)

View Comments and Join the Discussion!

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com